HoyleCohen’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $667K | Buy |
23,850
+2,678
| +13% | +$74.9K | 0.05% | 166 |
|
2024
Q1 | $588K | Sell |
21,172
-2,476
| -10% | -$68.7K | 0.04% | 188 |
|
2023
Q4 | $681K | Sell |
23,648
-4,372
| -16% | -$126K | 0.06% | 172 |
|
2023
Q3 | $929K | Sell |
28,020
-1,945
| -6% | -$64.5K | 0.09% | 142 |
|
2023
Q2 | $1.1M | Buy |
29,965
+110
| +0.4% | +$4.04K | 0.1% | 137 |
|
2023
Q1 | $1.22M | Buy |
29,855
+2,270
| +8% | +$92.6K | 0.11% | 128 |
|
2022
Q4 | $1.41M | Sell |
27,585
-242
| -0.9% | -$12.4K | 0.14% | 121 |
|
2022
Q3 | $1.22M | Sell |
27,827
-1,290
| -4% | -$56.5K | 0.13% | 122 |
|
2022
Q2 | $1.53M | Buy |
29,117
+432
| +2% | +$22.7K | 0.16% | 115 |
|
2022
Q1 | $1.49M | Buy |
28,685
+94
| +0.3% | +$4.87K | 0.13% | 123 |
|
2021
Q4 | $1.69M | Sell |
28,591
-196
| -0.7% | -$11.6K | 0.14% | 119 |
|
2021
Q3 | $1.24M | Buy |
28,787
+639
| +2% | +$27.5K | 0.12% | 126 |
|
2021
Q2 | $1.1K | Buy |
28,148
+534
| +2% | +$21 | 0.09% | 134 |
|
2021
Q1 | $1M | Buy |
27,614
+12,404
| +82% | +$449K | 0.1% | 137 |
|
2020
Q4 | $560K | Buy |
15,210
+1,007
| +7% | +$37.1K | 0.06% | 151 |
|
2020
Q3 | $495K | Buy |
14,203
+1,335
| +10% | +$46.5K | 0.07% | 136 |
|
2020
Q2 | $399K | Buy |
12,868
+139
| +1% | +$4.31K | 0.07% | 137 |
|
2020
Q1 | $394K | Hold |
12,729
| – | – | 0.08% | 134 |
|
2019
Q4 | $473K | Buy |
12,729
+473
| +4% | +$17.6K | 0.08% | 142 |
|
2019
Q3 | $418K | Buy |
12,256
+15
| +0.1% | +$512 | 0.07% | 148 |
|
2019
Q2 | $503K | Sell |
12,241
-97
| -0.8% | -$3.99K | 0.09% | 137 |
|
2019
Q1 | $497K | Buy |
12,338
+1,803
| +17% | +$72.6K | 0.09% | 134 |
|
2018
Q4 | $436K | Sell |
10,535
-824
| -7% | -$34.1K | 0.09% | 130 |
|
2018
Q3 | $475K | Buy |
11,359
+202
| +2% | +$8.45K | 0.09% | 126 |
|
2018
Q2 | $384K | Sell |
11,157
-2,016
| -15% | -$69.4K | 0.08% | 133 |
|
2018
Q1 | $444K | Buy |
13,173
+2,005
| +18% | +$67.6K | 0.09% | 120 |
|
2017
Q4 | $384K | Buy |
+11,168
| New | +$384K | 0.08% | 122 |
|